Awm Investment Company, Inc. Cognition Therapeutics Inc Transaction History
Awm Investment Company, Inc.
- $650 Million
- Q2 2024
A detailed history of Awm Investment Company, Inc. transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Awm Investment Company, Inc. holds 650,000 shares of CGTX stock, worth $331,500. This represents 0.17% of its overall portfolio holdings.
Number of Shares
650,000
Previous 650,000
-0.0%
Holding current value
$331,500
Previous $1.18 Million
8.79%
% of portfolio
0.17%
Previous 0.18%
Shares
1 transactions
Others Institutions Holding CGTX
# of Institutions
48Shares Held
7.64MCall Options Held
0Put Options Held
0-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$1.12 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.15MShares$585,2520.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL500KShares$255,0000.01% of portfolio
-
Timelo Investment Management Inc.361KShares$184,3120.35% of portfolio
-
Aigh Capital Management LLC Baltimore, MD301KShares$153,3900.18% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $11.6M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...